Newronika: Valuation, Funding & Investors
Newronika is a global leader in advanced deep brain stimulation, specializing in the development of an adaptive DBS system. This innovative platform is designed to deliver precision therapy to improve symptom relief and reduce side effects for Parkinson's disease patients. The company focuses on expanding clinical validation and commercialization efforts, advancing its product pipeline, and fostering strategic collaborations in the medical device engineering and neuroscience sectors.
Leadership & Board
- Current Number of Employees
- 28
- Current LinkedIn Followers
- 6,079
Latest Estimated Valuation
- Total Amount Raised
- $28M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $14M
- Latest Funding Round
- Series B
Employee Trend
Newronika had 28 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Newronika had 6,079 followers as of November 16, 2026. The number of followers increased by 24 (0.40%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Mar 13, 2025 | Series B | $14.20M | ― |
| Feb 13, 2025 | Series B | $13.60M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| ENEA Tech e Biomedical | Series B |
| Wille Finance | Series B |
| Fondazione ENEA Tech e Biomedical | Series B |
| Indaco Venture Partners SGR | Series B |
| Innogest SGR | Series B |
| TNBT Capital | Series B |
| F3F | Series B |
Similar Companies
A snapshot of private companies similar to Newronika, helping you discover and navigate related company profiles.
Related News and Analysis








